Overview of Dr. Razavi
Dr. Pedram Razavi is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Tehran University of Medical Sciences School of Medicine and has been in practice 16 years. He is one of 468 doctors at Memorial Sloan-Kettering Cancer Center who specialize in Oncology. He has more than 90 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Southern CaliforniaPhD, Cancer epidemiology , 2005 - 2009
University of Southern CaliforniaMPH, 2005 - 2007
Tehran University of Medical Sciences School of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
CA State Medical License 2013 - Present
NJ State Medical License 2020 - 2025
NY State Medical License 2013 - 2024
Publications & Presentations
PubMed
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Fatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, Edaise M da Silva, Anne Grabenstetter, Sahar Jalali, Andrea M Gazzo, Higinio Dopeso, Antonio Marra, David N Br...> ;Modern Pathology. 2023 Nov 3- 1 citations
Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer.
Sungsoo Kim, Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K Soni, Gary Schwartz, Julia E McGuinness, Hanina Hibshoosh, Pedram Razavi, Minah Kim, Sarat Chandarlapa...> ;Cell Reports. 2023 Nov 28 Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17- Join now to see all
Journal Articles
Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy
Elizabeth J Sutton, Lior Z Braunstein, Yolanda Bryce, Jill S Gluskin, Pedram Razavi, JAMA Network Open
Lectures
A deep dive into the cfDNA pool: Clonal hematopoiesis as a major source of somatic mutations
AACR Advances in Liquid Biopsies, Miami - 1/15/2020The Genomic Landscape of Endocrine-Resistant Metastatic Breast Cancer
San Antonio Breast Cancer Symposium - 12/10/2019Molecular profiling of ER+ metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors.
2019 ASCO Annual Meeting - 6/1/2019- Join now to see all
Press Mentions
Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
SABCS 2021: Understanding and Applying Liquid BiopsiesMarch 1st, 2022
Grail Passes Early Test in Quest to Find Cancer in BloodJune 6th, 2017
- Join now to see all
